{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T05:18:44Z","timestamp":1792646324931,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.jns.2010.07.013","type":"journal-article","created":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T09:15:13Z","timestamp":1283332513000},"page":"153-157","source":"Crossref","is-referenced-by-count":81,"title":["Pronounced association of elevated serum homocysteine with stroke in subgroups of individuals: A nationwide study"],"prefix":"10.1016","volume":"298","author":[{"given":"Amytis","family":"Towfighi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Markovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Ovbiagele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jns.2010.07.013_bb0005","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S1474-4422(07)70200-4","article-title":"Is homocysteine a causal and treatable risk factor for stroke?","volume":"6","author":"Hankey","year":"2007","journal-title":"Lancet Neurol"},{"issue":"6","key":"10.1016\/j.jns.2010.07.013_bb0010","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1161\/ATVBAHA.108.162743","article-title":"Homocysteine or renal impairment: which is the real cardiovascular risk factor?","volume":"28","author":"Potter","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"10.1016\/j.jns.2010.07.013_bb0015","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/jama.291.5.565","article-title":"Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial","volume":"291","author":"Toole","year":"2004","journal-title":"JAMA"},{"issue":"22","key":"10.1016\/j.jns.2010.07.013_bb0020","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1001\/jama.296.22.2720","article-title":"Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials","volume":"296","author":"Bazzano","year":"2006","journal-title":"JAMA"},{"issue":"15","key":"10.1016\/j.jns.2010.07.013_bb0025","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJMoa055227","article-title":"Homocysteine lowering and cardiovascular events after acute myocardial infarction","volume":"354","author":"Bonaa","year":"2006","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.jns.2010.07.013_bb0030","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1001\/jama.300.7.795","article-title":"Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial","volume":"300","author":"Ebbing","year":"2008","journal-title":"JAMA"},{"issue":"17","key":"10.1016\/j.jns.2010.07.013_bb0035","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1001\/jama.299.17.2027","article-title":"Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial","volume":"299","author":"Albert","year":"2008","journal-title":"JAMA"},{"issue":"15","key":"10.1016\/j.jns.2010.07.013_bb0040","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMoa060900","article-title":"Homocysteine lowering with folic acid and B vitamins in vascular disease","volume":"354","author":"Lonn","year":"2006","journal-title":"N Engl J Med"},{"issue":"9576","key":"10.1016\/j.jns.2010.07.013_bb0045","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/S0140-6736(07)60854-X","article-title":"Efficacy of folic acid supplementation in stroke prevention: a meta-analysis","volume":"369","author":"Wang","year":"2007","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jns.2010.07.013_bb0050","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1747-4949.2007.00111.x","article-title":"VITATOPS, the VITAmins TO prevent stroke trial: rationale and design of a randomised trial of B-vitamin therapy in patients with recent transient ischaemic attack or stroke (NCT00097669) (ISRCTN74743444)","volume":"2","author":"Hankey","year":"2007","journal-title":"Int J Stroke"},{"issue":"3","key":"10.1016\/j.jns.2010.07.013_bb0055","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ahj.2006.03.004","article-title":"Rationale and design of the Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT) trial","volume":"152","author":"Bostom","year":"2006","journal-title":"Am Heart J"},{"issue":"9","key":"10.1016\/j.jns.2010.07.013_bb0060","first-page":"830","article-title":"Homocysteine-lowering therapy: a role in stroke prevention?","volume":"6","author":"Spence","year":"2007","journal-title":"Neurol"},{"issue":"11","key":"10.1016\/j.jns.2010.07.013_bb0065","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/01.STR.0000185929.38534.f3","article-title":"Vitamin Intervention For Stroke Prevention trial: an efficacy analysis","volume":"36","author":"Spence","year":"2005","journal-title":"Stroke"},{"issue":"32","key":"10.1016\/j.jns.2010.07.013_bb0070","first-page":"1","article-title":"Plan and operation of the Third National Health and Nutrition Examination Survey, 1988\u201394. Series 1: programs and collection procedures","volume":"1","year":"1994","journal-title":"Vital Health Stat 1"},{"issue":"2","key":"10.1016\/j.jns.2010.07.013_bb0075","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ahj.2005.04.025","article-title":"Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials","volume":"151","year":"2006","journal-title":"Am Heart J"},{"issue":"19","key":"10.1016\/j.jns.2010.07.013_bb0080","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1056\/NEJM199905133401901","article-title":"The effect of folic acid fortification on plasma folate and total homocysteine concentrations","volume":"340","author":"Jacques","year":"1999","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jns.2010.07.013_bb0085","doi-asserted-by":"crossref","first-page":"1563S","DOI":"10.1093\/ajcn\/86.5.1563S","article-title":"Homocysteine, vitamins, and vascular disease prevention","volume":"86","author":"McCully","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jns.2010.07.013_bb0090","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39(2 Suppl 1)","year":"2002","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.jns.2010.07.013_bb0095","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1161\/STROKEAHA.108.535237","article-title":"Ethnicity does not affect the homocysteine-lowering effect of B-vitamin therapy in Singaporean stroke patients","volume":"40","author":"Kasiman","year":"2009","journal-title":"Stroke"},{"issue":"12","key":"10.1016\/j.jns.2010.07.013_bb0100","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/aje\/kwf157","article-title":"Homocysteine and blood pressure in the Third National Health and Nutrition Examination Survey, 1988-1994","volume":"156","author":"Lim","year":"2002","journal-title":"Am J Epidemiol"},{"issue":"12","key":"10.1016\/j.jns.2010.07.013_bb0105","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1161\/01.STR.29.12.2473","article-title":"Total homocyst(e)ine concentration and the likelihood of nonfatal stroke: results from the Third National Health and Nutrition Examination Survey, 1988-1994","volume":"29","author":"Giles","year":"1998","journal-title":"Stroke"},{"issue":"10","key":"10.1016\/j.jns.2010.07.013_bb0110","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1001\/archneur.1997.00550220074017","article-title":"Features, symptoms, and neurophysiological findings in stroke associated with hyperhomocysteinemia","volume":"54","author":"Evers","year":"1997","journal-title":"Arch Neurol"},{"issue":"11","key":"10.1016\/j.jns.2010.07.013_bb0115","first-page":"791","article-title":"Further evidence of interrelation between homocysteine and hypertension in stroke patients: a cross-sectional study","volume":"5","author":"Mizrahi","year":"2003","journal-title":"Isr Med Assoc J"},{"issue":"6","key":"10.1016\/j.jns.2010.07.013_bb0120","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1161\/01.STR.0000127813.12854.9c","article-title":"Folate intake and risk of stroke among women","volume":"35","author":"Al-Delaimy","year":"2004","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.jns.2010.07.013_bb0125","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1161\/01.STR.0000106762.55994.86","article-title":"Folate, vitamin B6, and B12 intakes in relation to risk of stroke among men","volume":"35","author":"He","year":"2004","journal-title":"Stroke"},{"issue":"7","key":"10.1016\/j.jns.2010.07.013_bb0130","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1161\/01.STR.0000169934.96354.3a","article-title":"Folate, vitamin B12, and risk of ischemic and hemorrhagic stroke: a prospective, nested case-referent study of plasma concentrations and dietary intake","volume":"36","author":"Van Guelpen","year":"2005","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.jns.2010.07.013_bb0135","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1161\/01.STR.0000014607.90464.88","article-title":"Dietary intake of folate and risk of stroke in US men and women: NHANES I Epidemiologic Follow-up Study. National Health and Nutrition Examination Survey","volume":"33","author":"Bazzano","year":"2002","journal-title":"Stroke"},{"issue":"12","key":"10.1016\/j.jns.2010.07.013_bb0140","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1161\/STROKEAHA.108.524934","article-title":"Is ischemic stroke risk related to folate status or other nutrients correlated with folate intake?","volume":"39","author":"Weng","year":"2008","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.jns.2010.07.013_bb0145","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1161\/STROKEAHA.108.529503","article-title":"Homocysteine-lowering therapy and stroke risk, severity, and disability: additional findings from the HOPE 2 trial","volume":"40","author":"Saposnik","year":"2009","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.jns.2010.07.013_bb0150","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1159\/000013486","article-title":"Effect of usual doses of folate supplementation on elevated plasma homocyst(e)ine in hemodialysis patients: no difference between 1 and 5mg daily","volume":"19","author":"Spence","year":"1999","journal-title":"Am J Nephrol"},{"issue":"7","key":"10.1016\/j.jns.2010.07.013_bb0155","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1161\/01.STR.31.7.1602","article-title":"Validity of self-reported stroke: The Tromso Study","volume":"31","author":"Engstad","year":"2000","journal-title":"Stroke"},{"issue":"8","key":"10.1016\/j.jns.2010.07.013_bb0160","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1161\/01.STR.26.8.1334","article-title":"Validation of a population screening questionnaire to assess prevalence of stroke","volume":"26","author":"O'Mahony","year":"1995","journal-title":"Stroke"},{"issue":"9","key":"10.1016\/j.jns.2010.07.013_bb0165","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1161\/01.STR.0000086753.00555.0D","article-title":"Elevated plasma homocysteine was associated with hemorrhagic and ischemic stroke, but methylenetetrahydrofolate reductase gene C677T polymorphism was a risk factor for thrombotic stroke: a Multicenter Case-Control Study in China","volume":"34","author":"Li","year":"2003","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.jns.2010.07.013_bb0170","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1161\/01.STR.0000060202.63475.BA","article-title":"Hyperhomocysteinemia is associated with the presence of left atrial thrombus in stroke patients with nonvalvular atrial fibrillation","volume":"34","author":"Ay","year":"2003","journal-title":"Stroke"},{"issue":"9","key":"10.1016\/j.jns.2010.07.013_bb0175","first-page":"1205","article-title":"The association between hyperhomocysteinemia and ischemic stroke in patients with non-valvular atrial fibrillation","volume":"90","author":"Loffredo","year":"2005","journal-title":"Haematologica"},{"issue":"10","key":"10.1016\/j.jns.2010.07.013_bb0180","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1161\/01.STR.0000183620.06179.7b","article-title":"Culprit factors for the failure of well-conducted warfarin therapy to prevent ischemic events in patients with atrial fibrillation: the role of homocysteine","volume":"36","author":"Poli","year":"2005","journal-title":"Stroke"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X10003369?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X10003369?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T20:58:59Z","timestamp":1559509139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X10003369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":36,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0022510X10003369"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2010.07.013","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}